Suppr超能文献

使用链脲佐菌素诱导的Wistar大鼠模型对阿萨姆邦将D. Don作为抗糖尿病植物的民间用法进行体内验证。

In Vivo Validation of Folkloric Use of D. Don as Antidiabetic Plant in Assam, Using Streptozotocin Induced Wister Rat Model.

作者信息

Bhuyan Biman, Chetia Dipak

机构信息

Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam 786004 India.

出版信息

Indian J Clin Biochem. 2020 Apr;35(2):225-231. doi: 10.1007/s12291-019-00819-y. Epub 2019 Mar 6.

Abstract

D. Don belonging to the family Costaceae is one of the most commonly used plant among traditional healers in the upper Assam region in India, specifically used in the treatment of diabetes. Aerial parts of the plant are said to have potent anti diabetic property. The present study was aimed to evaluate the traditionally claimed antidiabetic activity of aerial parts of in animal models. Healthy male Wister rats (120 ± 30 gm) were used in the study and diabetes was induced by Streptozotocin (STZ) i.p. prepared by dissolving in citrate buffer (pH 4.5), along with nicotinamide (120 mg/kg/b wt). Diabetic rats were treated for 14 days with daily doses of methanolic extract of (MECP) in three different scheduled amounts (50, 100 and 200 mg/kg/b wt; p.o.). Control rats were treated with 0.3% CMC (Carboxy Methyl Cellulose) suspension (10 ml/kg/b wt; p.o.). Blood glucose level and plasma lipid profile was examined on 1st, 7th, 14th and 21st day 1 h after treatment. On the last day, 1 h after the treatment, animals were sacrificed followed by isolation of pancreas and liver for histopathological examination. The results were compared with that of the standard group treated with Glibenclamide (10 mg/kg/day; p.o). Comparison of the experimental data of different cohorts demonstrated the potential antidiabetic activity of however the highest dose of 200 mg/kg/b wt; p.o. of MECP significantly ( < 0.05) reversed the STZ induced diabetic parameters (increased blood glucose level, altered plasma profile and histoarchitecture of the pancreatic and hepatic cells) that is comparable with that of the standard. The observed results suggest anti diabetic efficacy of thereby uphelding the folkloric usage.

摘要

隶属于闭鞘姜科的闭鞘姜是印度上阿萨姆邦地区传统治疗师最常用的植物之一,特别用于治疗糖尿病。据说该植物的地上部分具有强大的抗糖尿病特性。本研究旨在评估闭鞘姜地上部分在动物模型中传统上所宣称的抗糖尿病活性。研究中使用了健康的雄性Wistar大鼠(120±30克),通过腹腔注射链脲佐菌素(STZ)诱导糖尿病,STZ溶解在柠檬酸盐缓冲液(pH 4.5)中,并与烟酰胺(120毫克/千克/体重)一起使用。糖尿病大鼠每天以三种不同的预定剂量(50、100和200毫克/千克/体重;口服)接受闭鞘姜甲醇提取物(MECP)治疗14天。对照大鼠接受0.3%羧甲基纤维素(CMC)悬浮液(10毫升/千克/体重;口服)治疗。在治疗后第1、7、14和21天的治疗后1小时检查血糖水平和血浆脂质谱。在最后一天,治疗后1小时,处死动物,然后分离胰腺和肝脏进行组织病理学检查。将结果与用格列本脲治疗(10毫克/千克/天;口服)的标准组进行比较。不同队列的实验数据比较表明闭鞘姜具有潜在的抗糖尿病活性,然而,MECP口服剂量为200毫克/千克/体重时显著(P<0.05)逆转了STZ诱导的糖尿病参数(血糖水平升高、血浆谱改变以及胰腺和肝细胞的组织结构改变),这与标准组相当。观察到的结果表明闭鞘姜具有抗糖尿病功效,从而证实了其民间用法。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验